Bogardus Medical Systems Inc

Bogardus Medical Systems Inc (BMSi), headquartered in Oklahoma City, develops ONCOCHART, a specialty-specific electronic medical record and practice management system designed exclusively for radiation oncology practices. Founded by radiation oncologist Dr. Carl Bogardus, the company has been producing the ONCOCHART program since 2003. Unlike general ambulatory EHR systems, ONCOCHART focuses specifically on the unique workflows and billing requirements of radiation oncology, offering advanced charge capture, clinical documentation, and scheduling capabilities tailored to cancer treatment centers. The system provides Medicare-compliant documentation tools that eliminate much of the need for dictation and transcription, while ensuring full compliance with complex radiation oncology billing rules and CMS regulations. ONCOCHART integrates with existing radiation and verification (R&V) systems, functioning as an enhancement rather than replacement, and includes specialty-specific features such as customizable treatment management charge billing, physics charge tracking, and radiation-specific CPT code management. The cloud-based system serves radiation oncology departments within hospitals, cancer centers, and standalone radiation therapy practices. BMSi differentiates itself through its narrow specialty focus and personalized customer service model, maintaining a small team that provides customized configurations and responsive support. The company partners with leading healthcare IT vendors like DrFirst for e-prescribing capabilities, including electronic prescribing for controlled substances (EPCS), which is particularly important given that oncologists frequently prescribe scheduled medications. BMSi also offers BMSi Seminars to help practices maximize clinic efficiency and stay current with evolving Medicare billing and coding requirements. With approximately 14 known implementations primarily in the United States hospital and health care sector, ONCOCHART holds a small but specialized position in the oncology information systems market, competing against larger vendors like Varian, Elekta, and Epic that offer radiation oncology modules within broader platforms.